Boiling Histotripsy Ablation of Renal Cell Carcinoma in the Eker Rat Promotes a Systemic Inflammatory Response.
Focused ultrasound
High-intensity focused ultrasound
Histotripsy
Immune response
Kidney cancer
Renal carcinoma
T cells
Journal
Ultrasound in medicine & biology
ISSN: 1879-291X
Titre abrégé: Ultrasound Med Biol
Pays: England
ID NLM: 0410553
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
23
02
2018
revised:
31
08
2018
accepted:
06
09
2018
pubmed:
21
10
2018
medline:
20
6
2019
entrez:
21
10
2018
Statut:
ppublish
Résumé
Boiling histotripsy (BH) is an experimental focused ultrasound technique that produces non-thermal mechanical ablation. We evaluated the feasibility, short-term histologic effects and the resulting acute inflammatory response to BH ablation of renal cell carcinoma (RCC) in the Eker rat. Genotyped Eker rats were monitored for de novo RCCs with serial ultrasound (US) imaging. When tumors were ≥8 mm, rats underwent ultrasound-guided extracorporeal ablation of the tumor with BH, a pulsed focused US technique that produces non-thermal mechanical ablation of targeted tissues, or a sham US procedure. Treatments targeted approximately 50% of the largest RCC with a margin of normal kidney. BH treated rats were euthanized at 1 (n = 4) or 48 (n = 4) h, and sham patients (n = 4) at 48 h. Circulating plasma cytokine levels were assessed with multiplex assays before and at 0.25, 1, 4, 24 and 48 h following treatment. Kidneys were collected and processed for histologic assessment, immunohistochemistry and intrarenal cytokine concentration measurements. For statistical analysis Student's t-test was used. US-guided BH treatment was successful in all animals, producing hypoechoic regions within the targeted volume consistent with BH treatment effect. Grossly, regions of homogenized tissue were apparent with evidence of focal intra-parenchymal hemorrhage. Histologically, BH produced a sharply demarcated region of homogenized tumor and non-tumor tissue containing acellular debris. BH treatment was associated with significantly increased relative concentration of plasma TNF versus sham treatment (p < 0.05) and transient elevations in high-mobility group box 1 (HMGB1), IL-10 and IL-6 consistent with acute inflammatory response to trauma. Intrarenal cytokine concentrations followed the same trend. At 48 h, enhanced infiltration of CD8
Identifiants
pubmed: 30340920
pii: S0301-5629(18)30403-4
doi: 10.1016/j.ultrasmedbio.2018.09.006
pmc: PMC6546431
mid: NIHMS1507267
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
137-147Subventions
Organisme : NIBIB NIH HHS
ID : K01 EB015745
Pays : United States
Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.
Références
Mol Med. 2008 Jul-Aug;14(7-8):476-84
pubmed: 18431461
Cell Stem Cell. 2008 Mar 6;2(3):284-91
pubmed: 18371453
Int J Hyperthermia. 2015 Mar;31(2):145-62
pubmed: 25707817
J Exp Med. 2000 Aug 21;192(4):565-70
pubmed: 10952726
Phys Med Biol. 2012 Dec 7;57(23):8061-78
pubmed: 23159812
Dis Model Mech. 2009 May-Jun;2(5-6):206-10
pubmed: 19407324
J Acoust Soc Am. 2011 Nov;130(5):3498-510
pubmed: 22088025
Ultrasound Med Biol. 2013 Mar;39(3):424-38
pubmed: 23312958
J Clin Oncol. 2015 Jun 20;33(18):2013-20
pubmed: 25800770
J Transl Med. 2007 Jul 11;5:34
pubmed: 17625013
Injury. 2010 Dec;41(12):1323-7
pubmed: 20887988
Ultrasound Med Biol. 2015 Jun;41(6):1500-17
pubmed: 25813532
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8161-6
pubmed: 24843132
Urology. 2009 Oct;74(4):932-7
pubmed: 19628261
Radiology. 2011 Nov;261(2):375-91
pubmed: 22012904
Shock. 2009 Jul;32(1):17-22
pubmed: 19533845
Radiology. 2017 Apr;283(1):158-167
pubmed: 27802108
J Clin Invest. 2012 Aug;122(8):2711-9
pubmed: 22850880
J Am Soc Nephrol. 2011 May;22(5):802-9
pubmed: 21474561
Toxicol Pathol. 2002 Nov-Dec;30(6):675-80
pubmed: 12512868
Ultrasound Med Biol. 2006 Jan;32(1):115-29
pubmed: 16364803
Clin Cancer Res. 2014 Jun 1;20(11):2831-7
pubmed: 24879823
J Urol. 2009 Oct;182(4):1271-9
pubmed: 19683266
Br J Cancer. 2006 Oct 9;95(7):896-905
pubmed: 16953240
PLoS One. 2011 Apr 20;6(4):e18801
pubmed: 21533099
PLoS One. 2012;7(7):e41632
pubmed: 22911830
Nat Med. 2007 Sep;13(9):1050-9
pubmed: 17704786
Biochem Biophys Res Commun. 2008 Oct 31;375(4):645-50
pubmed: 18727919
Cancer Res. 2003 May 15;63(10):2675-80
pubmed: 12750296
Nat Rev Immunol. 2010 Dec;10(12):826-37
pubmed: 21088683
NMR Biomed. 2016 Jun;29(6):721-31
pubmed: 27061290
J Transl Med. 2017 Dec 13;15(1):252
pubmed: 29237455
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3507-12
pubmed: 23401516
Sci Rep. 2019 Dec 27;9(1):20176
pubmed: 31882870
Immunol Rev. 2007 Dec;220:60-81
pubmed: 17979840
Cancer Res. 2002 Oct 15;62(20):5645-50
pubmed: 12384518
BJU Int. 2012 Sep;110(6 Pt B):E281-6
pubmed: 22612555
Genes Cancer. 2011 Nov;2(11):1051-60
pubmed: 22737271
Neoplasma. 1981;28(6):697-703
pubmed: 7040995
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1167-72
pubmed: 25092317